Clinical Trial Update: Combined Treatment of Prolonged Exposure and Pramipexole for Posttraumatic Stress Disorder and Depression [Phase 3]

View source ↗

Summary

Phase 3 trial of combined prolonged exposure therapy and pramipexole for PTSD and major depressive disorder was terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Post-traumatic Stress Disorder

Drugs mentioned

• Pramipexole (pramipexole)

Snippet

Sponsor: Research Foundation for Mental Hygiene, Inc. | Conditions: PTSD, MDD | Phase 3 | Status: TERMINATED | Results posted: 2019-11-26